Abstract
Three new glycopeptide antibiotics, aridicins A, B, and C, produced by Kibdelosporangium aridum have a spectrum of antimicrobial activity in vitro which is similar to that of vancomycin. The antimicrobial activities of these glycopeptides against clinical bacterial isolates were compared with those of vancomycin and other related glycopeptide antibiotics in vitro by agar dilution and microtiter broth dilution tests and in vivo in mouse protection studies. In vitro they were somewhat less effective than vancomycin against strains of Staphylococcus aureus and less active against coagulase-negative Staphylococcus spp. However, they were more active than vancomycin against strains of Streptococcus faecalis and markedly superior to vancomycin and other glycopeptide antibiotics against strains of Clostridium difficile. In experimental infections, aridicin A was effective against strains of S. aureus, S. epidermidis, Streptococcus faecalis, and Streptococcus pyogenes, although its 50% effective doses were higher than those of vancomycin when administered after infection. After subcutaneous administration, aridicin A had a higher peak level in serum and a longer half-life than vancomycin or teicoplanin. The aridicins were markedly superior to vancomycin when administered prior to infection in mouse protection tests, indicating long-acting potential.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bardone M. R., Paternoster M., Coronelli C. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization. J Antibiot (Tokyo) 1978 Mar;31(3):170–177. doi: 10.7164/antibiotics.31.170. [DOI] [PubMed] [Google Scholar]
- Fekety R., Silva J., Buggy B., Deery H. G. Treatment of antibiotic-associated colitis with vancomycin. J Antimicrob Chemother. 1984 Dec;14 (Suppl 500):97–102. doi: 10.1093/jac/14.suppl_d.97. [DOI] [PubMed] [Google Scholar]
- Griffith R. S. Vancomycin use--an historical review. J Antimicrob Chemother. 1984 Dec;14 (Suppl 500):1–5. doi: 10.1093/jac/14.suppl_d.1. [DOI] [PubMed] [Google Scholar]
- Kirby W. M. Vancomycin therapy of severe staphylococcal infections. J Antimicrob Chemother. 1984 Dec;14 (Suppl 500):73–78. doi: 10.1093/jac/14.suppl_d.73. [DOI] [PubMed] [Google Scholar]
- Pallanza R., Berti M., Goldstein B. P., Mapelli E., Randisi E., Scotti R., Arioli V. Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics. J Antimicrob Chemother. 1983 May;11(5):419–425. doi: 10.1093/jac/11.5.419. [DOI] [PubMed] [Google Scholar]
- Shearer M. C., Actor P., Bowie B. A., Grappel S. F., Nash C. H., Newman D. J., Oh Y. K., Pan C. H., Nisbet L. J. Aridicins, novel glycopeptide antibiotics. I. Taxonomy, production and biological activity. J Antibiot (Tokyo) 1985 May;38(5):555–560. doi: 10.7164/antibiotics.38.555. [DOI] [PubMed] [Google Scholar]
- Sitrin R. D., Chan G. W., Dingerdissen J. J., Holl W., Hoover J. R., Valenta J. R., Webb L., Snader K. M. Aridicins, novel glycopeptide antibiotics. II. Isolation and characterization. J Antibiot (Tokyo) 1985 May;38(5):561–571. doi: 10.7164/antibiotics.38.561. [DOI] [PubMed] [Google Scholar]
- Watanakunakorn C. Mode of action and in-vitro activity of vancomycin. J Antimicrob Chemother. 1984 Dec;14 (Suppl 500):7–18. doi: 10.1093/jac/14.suppl_d.7. [DOI] [PubMed] [Google Scholar]
- Watanakunakorn C. The antibacterial action of vancomycin. Rev Infect Dis. 1981 Nov-Dec;3 Suppl:S210–S215. [PubMed] [Google Scholar]